Response to Letter to the Editor Regarding "Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis"

Brittney Lager; Jacob Liseno; Ivan Božin; Sarah M England; Sai L Shankar; Jason P Mendoza; James B Lewin

doi:10.1007/s40120-023-00536-y

Response to Letter to the Editor Regarding "Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis"

Neurol Ther. 2023 Dec;12(6):2199-2203. doi: 10.1007/s40120-023-00536-y. Epub 2023 Sep 14.

Authors

Brittney Lager¹, Jacob Liseno¹, Ivan Božin², Sarah M England², Sai L Shankar², Jason P Mendoza², James B Lewin³

Affiliations

¹ AcariaHealth, FL, Orlando, USA.
² Biogen Inc., Cambridge, MA, USA.
³ Biogen Inc., Cambridge, MA, USA. [email protected].

No abstract available

Keywords: Adherence; Dimethyl fumarate; Diroximel fumarate; Gastrointestinal side effects; Multiple sclerosis; Real-world treatment; Tolerability.

Publication types

Letter